miR-26a Induced the Suppression of Tumor Growth of Cholangiocarcinoma via KRT19 Approach

Oncotarget - United States
doi 10.18632/oncotarget.13229
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Serum miR-26a as a Diagnostic and Prognostic Biomarker in Cholangiocarcinoma

Oncotarget
Oncology
2015English

miR-34a-dependent Overexpression of Per1 Decreases Cholangiocarcinoma Growth

Journal of Hepatology
Hepatology
2016English

Hypoxia-Induced VEGF Enhances Tumor Survivability via Suppression of Serum Deprivation-Induced Apoptosis

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Downregulation of MALAT1 Alleviates Saturated Fatty Acid-Induced Myocardial Inflammatory Injury via the miR-26a/HMGB1/TLR4/NF-κB Axis

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2019English

miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2014English

miR-26a Enhances Autophagy to Protect Against Ethanol-Induced Acute Liver Injury

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2015English

miR-122 Regulates Hepatic Lipid Metabolism and Tumor Suppression

Journal of Clinical Investigation
Medicine
2012English

Long Noncoding RNA DLX6-AS1 Promotes Renal Cell Carcinoma Progression via miR-26a/PTEN Axis

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2017English

Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer

Asian Pacific Journal of Cancer Prevention
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy